Tumor News and Research

RSS

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

30 Aug 2022

Immune cells beyond CAR-T cells affect the durability of response to BCMA CAR T therapy in myeloma

Patients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer markers of immune cell exhaustion, and distinct changes to immune cell populations were more likely to have longer progression-free survival (PFS) after treatment with BCMA-targeted T-cell therapy.

30 Aug 2022

Study reveals a vital route through which fascin promotes cancer development

The study reveals an important route through which fascin promotes cancer development and provides insights into potential pathways that could block its action.

30 Aug 2022

Using deep learning to guide the selection of chemotherapy after surgery for colorectal cancer patients

Among patients with colorectal cancer spread to lymph nodes, a deep learning marker can identify one-third with excellent prognosis and consequently no need for adjuvant chemotherapy.

30 Aug 2022

Gothenburg scientists discover possible new cancer treatment target

Researchers at the University of Gothenburg have identified a previously unknown mechanism controlling tumor growth in cultured cells and mice.

30 Aug 2022

Discovery paves the way for specific therapies for common form of childhood brain and spine tumor

A study conducted by researchers in Brazil, Australia, Austria and the United States has made significant discoveries about a type of pediatric cancer with no approved drugs for treatment and with a low survival rate.

29 Aug 2022

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to overcome tumor-induced immunosuppression.

29 Aug 2022

Researchers discover new therapeutic target for triple-negative breast cancer

Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative.

29 Aug 2022

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

The immune system has evolved to safeguard the body from a wildly diverse range of potential threats. Among these are bacterial diseases, including plague, cholera, diphtheria and Lyme disease, and viral contagions such as influenza, Ebola virus and SARS CoV-2.

29 Aug 2022

High-throughput proteomics reveals pregnancy-specific responses to COVID-19

Researchers evaluated pregnancy-specific responses to SARS-CoV-2 infection.

29 Aug 2022

Study explores a potential new therapeutic approach for triple negative breast cancer treatment

Researchers are exploring a potential new therapeutic approach for triple negative breast cancer treatment.

26 Aug 2022

New approach using CRISPR can engineer massive quantities of cells for therapeutic applications

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications.

25 Aug 2022

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers investigated the potential anti-COVID-19 activity of traditional Chinese medicine.

25 Aug 2022

Tumor News and Research

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

Immune cells beyond CAR-T cells affect the durability of response to BCMA CAR T therapy in myeloma

Study reveals a vital route through which fascin promotes cancer development

Using deep learning to guide the selection of chemotherapy after surgery for colorectal cancer patients

Gothenburg scientists discover possible new cancer treatment target

Discovery paves the way for specific therapies for common form of childhood brain and spine tumor

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

Researchers discover new therapeutic target for triple-negative breast cancer

Oncolytic viruses boost the immune capacity to effectively target and destroy cancer cells

High-throughput proteomics reveals pregnancy-specific responses to COVID-19

Study explores a potential new therapeutic approach for triple negative breast cancer treatment

New approach using CRISPR can engineer massive quantities of cells for therapeutic applications

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Soft-tissue sarcomas produce a protein that make immune cells 'go bad'

Researchers discover a new class of more potent and less toxic drugs for leukemia patients

Using the power of CRISPR to engineer better, stronger, longer-lived T cells

Researchers identify a potential new therapeutic approach to fight angioimmunoblastic T-cell lymphoma

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

Study gains insight into how deadliest form of brain cancer returns

New combination therapy shows potential to improve survival in children with neuroblastoma

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News